GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $685,000 | -2.4% | 15,737 | -2.4% | 0.02% | +13.3% |
| Q1 2022 | $702,000 | -5.9% | 16,120 | -4.7% | 0.02% | 0.0% |
| Q4 2021 | $746,000 | +6.3% | 16,910 | -7.9% | 0.02% | 0.0% |
| Q3 2021 | $702,000 | -13.0% | 18,368 | -9.4% | 0.02% | -6.2% |
| Q2 2021 | $807,000 | -19.4% | 20,263 | -27.7% | 0.02% | -23.8% |
| Q1 2021 | $1,001,000 | -90.0% | 28,044 | -89.7% | 0.02% | -90.8% |
| Q4 2020 | $10,029,000 | -18.2% | 272,516 | -16.3% | 0.23% | -26.4% |
| Q3 2020 | $12,257,000 | -7.0% | 325,639 | +0.8% | 0.31% | -8.3% |
| Q2 2020 | $13,179,000 | +5.2% | 323,095 | -2.3% | 0.34% | -8.6% |
| Q1 2020 | $12,532,000 | -23.1% | 330,740 | -4.7% | 0.37% | +4.8% |
| Q4 2019 | $16,300,000 | -7.7% | 346,884 | -16.2% | 0.35% | -44.4% |
| Q3 2019 | $17,663,000 | +0.5% | 413,851 | -5.8% | 0.64% | 0.0% |
| Q2 2019 | $17,578,000 | -6.8% | 439,239 | -2.7% | 0.64% | +60.1% |
| Q1 2019 | $18,865,000 | -6.7% | 451,423 | -14.7% | 0.40% | -51.6% |
| Q4 2018 | $20,227,000 | -8.3% | 529,362 | -3.6% | 0.82% | +2.6% |
| Q3 2018 | $22,060,000 | -3.6% | 549,174 | -3.3% | 0.80% | -4.5% |
| Q2 2018 | $22,889,000 | -7.6% | 567,827 | -10.5% | 0.84% | -2.7% |
| Q1 2018 | $24,781,000 | +29.2% | 634,283 | +17.3% | 0.86% | +27.5% |
| Q4 2017 | $19,176,000 | -20.0% | 540,612 | -8.5% | 0.68% | -21.6% |
| Q3 2017 | $23,975,000 | -7.0% | 590,512 | -1.2% | 0.86% | -8.4% |
| Q2 2017 | $25,780,000 | -0.3% | 597,869 | -2.5% | 0.94% | +5.1% |
| Q1 2017 | $25,858,000 | +20.0% | 613,324 | +9.6% | 0.90% | +9.7% |
| Q4 2016 | $21,544,000 | -9.1% | 559,430 | +1.8% | 0.82% | +2.8% |
| Q3 2016 | $23,702,000 | -23.8% | 549,555 | -23.4% | 0.80% | +1.0% |
| Q2 2016 | $31,099,000 | +102.2% | 717,549 | +89.1% | 0.79% | +113.6% |
| Q1 2016 | $15,383,000 | +0.1% | 379,368 | -0.4% | 0.37% | -5.1% |
| Q4 2015 | $15,374,000 | -3.0% | 381,024 | -7.6% | 0.39% | -4.0% |
| Q3 2015 | $15,856,000 | -10.8% | 412,368 | -3.3% | 0.40% | +1.2% |
| Q2 2015 | $17,767,000 | -9.6% | 426,577 | +0.1% | 0.40% | -6.1% |
| Q1 2015 | $19,662,000 | -1.6% | 426,045 | -8.8% | 0.43% | +5.4% |
| Q4 2014 | $19,975,000 | -5.6% | 467,364 | +1.5% | 0.40% | -7.6% |
| Q3 2014 | $21,164,000 | -9.9% | 460,383 | +4.8% | 0.44% | -3.5% |
| Q2 2014 | $23,488,000 | +26.2% | 439,185 | +26.1% | 0.45% | +22.4% |
| Q1 2014 | $18,611,000 | +19.0% | 348,326 | +18.9% | 0.37% | +19.4% |
| Q4 2013 | $15,643,000 | +11.1% | 292,987 | +4.4% | 0.31% | +2.3% |
| Q3 2013 | $14,084,000 | +7.3% | 280,735 | +6.9% | 0.30% | +7.8% |
| Q2 2013 | $13,127,000 | – | 262,699 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |